Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fenoldopam for Hypertensive Emergency
CTR20170681Phase 2Suspended
- Sponsor
- Yangtze River Pharmaceutical Group
- Start
- Aug 2017
- Modality
- Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fenoldopam in hypertensive emergency, sponsored by Yangtze River Pharmaceutical Group. Started Aug 2017; status: suspended.
02
Drugs
fenoldopam
03
Conditions
hypertensive emergency
Beyond the preview
Go deeper on CTR20170681.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170681.